Diabetic Medicine

The diabetes epidemic
pp. 1-1(1)
Author: Hitman, G. A.

Banting Memorial Lecture 2010 . Type 2 diabetes as an `infectious' disease: is this the Black Death of the 21st century?
pp. 2-9(8)
Authors: Matthews, D. R.; Matthews, P. C.

Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis
pp. 10-18(9)
Authors: Verbeeten, K. C.; Elks, C. E.; Daneman, D.; Ong, K. K.

Combined cardiovascular and diabetes risk assessment in primary care
pp. 19-22(4)
Authors: Preiss, D.; Khunti, K.; Sattar, N.

The potential for a two-stage diabetes risk algorithm combining non-laboratory-based scores with subsequent routine non-fasting blood tests: results from prospective studies in older men and women
pp. 23-30(8)
Authors: Wannamethee, S. G.; Papacosta, O.; Whincup, P. H.; Thomas, M. C.; Carson, C.; Lawlor, D. A.; Ebrahim, S.; Sattar, N.

HbA_1c measurement for the diagnosis of diabetes: is it enough?
pp. 31-35(5)
Authors: Cavagnolli, G.; Comerlato, J.; Comerlato, C.; Renz, P. B.; Gross, J. L.; Camargo, J. L.

HbA_1c in diagnosing and predicting Type 2 diabetes in impaired glucose tolerance: the Finnish Diabetes Prevention Study
pp. 36-42(7)
Authors: Pajunen, P.; Peltonen, M.; Eriksson, J. G.; Ilanne-Parikka, P.; Aunola, S.; Keinänen-Kiukaanniemi, S.; Uusitupa, M.; Tuomilehto, J.; Lindström, J.

Parity and risk of diabetes in a Danish nationwide birth cohort
pp. 43-47(5)
Authors: Naver, K. V.; Lundbye-Christensen, S.; Gorst-Rasmussen, A.; Nilas, L.; Secher, N. J.; Rasmussen, S.; Ovesen, P.

A retrospective study of the incidence of diagnosed Type 1 diabetes among children and adolescents in a large health organization in Israel, 2000-2008
pp. 48-53(6)
Authors: Sella, T.; Shoshan, A.; Goren, I.; Shalev, V.; Blumenfeld, O.; Laron, Z.; Chodick, G.

Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes
pp. 54-60(7)
Authors: Soldatos, G.; Jandeleit-Dahm, K.; Thomson, H.; Formosa, M.; D'orsa, K.; Calkin, A. C.; Cooper, M. E.; Ahimastos, A. A.; Kingwell, B. A.

Increased risk of cardiovascular disease in Type 1 diabetes: arterial exposure to remnant lipoproteins leads to enhanced deposition of cholesterol and binding to glycated extracellular matrix proteoglycans
pp. 61-72(12)
Authors: Mangat, R.; Su, J. W.; Lambert, J. E.; Clandinin, M. T.; Wang, Y.; Uwiera, R. R.; Forbes, J. M.; Vine, D. F.; Cooper, M. E.; Mamo, J. C.; Proctor, S. D.

Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Findings from the FRENA Registry
pp. 73-80(8)
Authors: Camafort, M.; Álvarez-Rodríguez, L. R.; Muñoz-Torrero, J. F. S.; Sahuquillo, J. C.; López-Jiménez, L.; Coll, R.; Monreal, M.

Chronic exertional compartment syndrome in diabetes mellitus
pp. 81-85(5)
Authors: Edmundsson, D.; Toolanen, G.

More co-morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinic
pp. 86-89(4)
Authors: van Steenbergen-Weijenburg, K. M.; van Puffelen, A. L.; Horn, E. K.; Nuyen, J.; Sytze van Dam, P.; van Benthem, T. B.; Beekman, A. T. F.; Rutten, F. F. H.; Hakkaart-van Roijen, L.; van der Feltz-Cornelis, C. M.

The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation is less accurate in patients with Type 2 diabetes when compared with healthy individuals
pp. 90-95(6)
Authors: Camargo, E. G.; Soares, A. A.; Detanico, A. B.; Weinert, L. S.; Veronese, F. V.; Gomes, E. C.; Silveiro, S. P.

Low serum bilirubin concentration in haemodialysis patients with Type 2 diabetes
pp. 96-99(4)
Authors: Fukui, M.; Tanaka, M.; Yamazaki, M.; Hasegawa, G.; Nishimura, M.; Iwamoto, N.; Ono, T.; Imai, S.; Nakamura, N.

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin
pp. 100-108(9)
Authors: Rutter, M. K.; Prais, H. R.; Charlton-Menys, V.; Gittins, M.; Roberts, C.; Davies, R. R.; Moorhouse, A.; Jinadev, P.; France, M.; Wiles, P. G.; Gibson, J. M.; Dean, J.; Kalra, P. A.; Cruickshank, J. K.; Durrington, P. N.

Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trial
pp. 109-116(8)
Authors: Satoh, J.; Yagihashi, S.; Baba, M.; Suzuki, M.; Arakawa, A.; Yoshiyama, T.; Shoji, S.

Self management and patient understanding of diabetes in the older person
pp. 117-122(6)
Authors: Hewitt, J.; Smeeth, L.; Chaturvedi, N.; Bulpitt, C. J.; Fletcher, A. E.

Response to Vischer et al. The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments
pp. 123-123(1)
Author: Chen, L.-Y.

Reply from Vischer et al. The high prevalence of malnutrition in elderly diabetic patients: implications for anti-diabetic drug treatments
pp. 123-124(2)
Author: Vischer, U. M.

Metformin may maintain weight loss in obese patients with dysglycaemia initially treated with rimonabant
pp. 124-125(2)
Authors: Dawson, A. J.; Mellor, D. D.; Sathyapalan, T.; Kilpatrick, E. S.; Atkin, S. L.

Endothelial dysfunctionl has vitamin D a role?
pp. 125-126(2)
Author: Boucher, B. J.

Response to Buscemi S et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes
pp. 126-126(1)
Authors: Zaccardi, F.; Pitocco, D.; Caputo, S.; Ghirlanda, G.

Reply from Buscemi S et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes. Authors' reply
pp. 127-128(2)
Authors: Buscemi, S.; Batsis, J. A.; Verga, S.

Erratum
pp. 129-129(1)